Physician

Jodi Lynne Belinski, MD

According to 2025 Medicare claims, Jodi Belinski, MD (NPI: 1295745941) practices family practice in the Sumter, SC market, with the plurality of this provider's patient population coming from Sumter, SC. This provider's primary affiliated billing organization is PRISMA HEALTH MEDICAL GROUP-MIDLANDS (NPI: 1275988321; TIN: 471345819) and primary practice location at 29150-4967. Belinski is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Belinski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 417 traditional Medicare patients, billed 4,090 HCPCS/CPT codes, and received $195,536 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,651 prescription claims across 654 beneficiaries totaling $699,564 in drug costs, led by Eliquis (Apixaban). DME data shows 380 claims. Open Payments data shows 6 records totaling $134. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $130,961 to $195,536. Similarly, Part D prescription costs have risen steadily, from $537,919 to $699,564. In contrast, DME billing represents a smaller volume and rose steadily, from $18,942 to $36,879.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	431	3,393	$130,961
2016	432	3,492	$130,116
2017	459	3,370	$119,672
2018	456	3,193	$113,562
2019	468	2,931	$114,799
2020	416	2,711	$105,988
2021	498	2,961	$141,025
2022	471	2,940	$145,260
2023	438	3,096	$181,692
2024	417	4,090	$195,536

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	357	10,575	$537,919
2016	372	10,130	$585,115
2017	390	10,316	$609,118
2018	393	10,339	$676,719
2019	408	9,457	$693,795
2020	393	8,998	$745,327
2021	442	8,537	$774,692
2022	513	9,316	$845,255
2023	521	9,622	$934,724
2024	654	8,651	$699,564

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	124	508	$22,863
2016	83	468	$20,497
2017	40	274	$5,671
2018	66	346	$7,199
2019	88	424	$8,206
2020	57	327	$9,501
2021	13	240	$8,156
2022	54	328	$15,598
2023	54	372	$18,905
2024	70	380	$18,150

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	269	269	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	386	991	$84
G0008	Administration of influenza virus vaccine	146	150	$30
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	314	685	$12
36415	Insertion of needle into vein for collection of blood sample	304	479	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	95	3,803	$72,693
Ozempic	Semaglutide	62	2,344	$66,821
Mounjaro	Tirzepatide	55	1,710	$63,147
Jardiance	Empagliflozin	61	2,580	$49,883
Januvia	Sitagliptin Phosphate	40	2,640	$48,900

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$6,171
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	30	$1,924
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	58	$1,636
A7030	Full face mask used with positive airway pressure device, each	N	N/R	17	$1,429
A7031	Face mask interface, replacement for full face mask, each	N	N/R	15	$1,414

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$134	Xeris Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jodi Lynne Belinski, MD?

Tedicare shows public-source Medicare data for Jodi Lynne Belinski, MD (NPI 1295745941), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jodi Lynne Belinski, MD have ACO affiliation data?

Jodi Lynne Belinski, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Jodi Lynne Belinski, MD?

Jodi Lynne Belinski, MD is linked to PRISMA HEALTH MEDICAL GROUP-MIDLANDS (billing NPI 1275988321) in the available physician profile data.

Does Jodi Lynne Belinski, MD have Open Payments data?

Jodi Lynne Belinski, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.